Journal Guide

Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others. Pharmaceutical Research publishes twelve issues a year.

Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers. The aims of the Journal are to:

Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of pharmaceutical products and molecular medicine. Related news and announcements can also published. Our aim is to publish as much as possible the theoretical and experimental details. Therefore, there is no restriction on the length of a paper. There are in addition three unique features: Manuscripts regarding research proposals and research ideas will be particularly welcomed. Electronic files regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, will be deposited as supplementary material. Samples of the pharmaceutical products can be deposited into the samples collection of MDPI.

Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications, and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds

Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by scientists and decision-makers most closely involved in this rapidly developing area. Pharmacogenomics aims at being an essential resource for keeping abreast of the latest developments in all areas of this exciting new field, and focuses on those aspects of most direct relevance to the pharmaceutical industry and wider clinical community.

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.